EVH:NYE-Evolent Health Inc (USD)

COMMON STOCK | Health Information Services |

Last Closing

USD 12.6

Change

+0.64 (+5.35)%

Market Cap

N/A

Volume

2.19M

Analyst Target

USD 11.67
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-01-08 )

Largest Industry Peers for Health Information Services

Symbol Name Price(Change) Market Cap
SOLV Solventum Corp.

-0.45 (-0.65%)

USD 10.78B
DOCS Doximity Inc

-0.48 (-0.87%)

USD 9.97B
WEAV Weave Communications Inc

-0.12 (-0.75%)

USD 1.13B
MPLN MultiPlan Corporation

+0.27 (+2.23%)

USD 0.23B
AMWL American Well Corp

-0.11 (-1.49%)

USD 0.11B
OWLT Owlet Inc

-0.03 (-0.67%)

USD 0.08B
TDOC Teladoc Inc

-0.21 (-2.10%)

N/A
FOXO FOXO Technologies Inc.

-0.02 (-5.92%)

N/A
PHR Phreesia Inc

+1.45 (+5.37%)

N/A
VEEV Veeva Systems Inc Class A

+5.57 (+2.63%)

N/A

ETFs Containing EVH

ACTV LeaderShares® Activist L.. 0.00 % 0.00 %

-0.13 (-0.40%)

N/A

Market Performance

  Market Performance vs. Industry/Classification (Health Information Services) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 12.00% 91% A- 98% N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return 12.00% 91% A- 98% N/A
Trailing 12 Months  
Capital Gain -61.92% 30% F 2% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -61.92% 30% F 2% F
Trailing 5 Years  
Capital Gain 27.14% 75% C 64% D
Dividend Return N/A N/A N/A N/A N/A
Total Return 27.14% 75% C 54% F
Average Annual (5 Year Horizon)  
Capital Gain 40.27% 100% F 91% A-
Dividend Return 40.27% 100% F 90% A-
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 74.66% 50% F 12% F
Risk Adjusted Return 53.94% 100% F 68% D+
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:
High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.